Biggest News Aggregation in the World
๐Ÿ“ฐ Micron News

Page 109 - Micron News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Micron. Real-time updates on events, politics, business and more.

How effective has the bivalent booster COVID vaccination been?

In a recent study published in the journal Eurosurveillance, researchers estimated the effectiveness of bivalent messenger ribonucleic acid (mRNA) vaccines targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 subvariant and the original Wuhan-Hu1 strain against Omicron infections in the vaccinated population of the Netherlands between 26 September and 19 December 2022.
United States Industry Focus Coronavirus Disease Covid 19 Ibonucleic Acid Ars Cov 2 Evere Acute Respiratory

Prior COVID highly protective against severe disease ten months post-infection

In a recent study published in the Lancet, researchers performed a systematic review of scientific literature published from inception up to September 31, 2022, that documented the reduction in risk of coronavirus disease 2019 (COVID-19) among individuals with a prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vis-ร -vis those with no COVID-19 history.
United States Caroline Stein Alih Mokdad Alihmokdad Eric Topol Erictopol European Union National Institutes Of Health

After a previous BA.1 infection, Omicron BA.4/5 infection is more likely than BA.2

In a recent study published in the journal Eurosurveillance, researchers investigated whether prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) vaccination protected against SARS-CoV-2 Omicron variant of concern (VOC) BA.4/5 sub-VOC or BA.2 sub-VOC infections.
Industry Focus Prior Omicron Coronavirus Disease Covid 19 Covid 19 Ars Cov 2 Evere Acute Respiratory

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Omicron has higher risk of in-hospital mortality compared to influenza

In a recent study published in the journal JAMA Network Open, researchers compared the hospital outcomes of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant with those of influenza patients in Switzerland, assess the current disease burden due to coronavirus disease 2019 (COVID-19).
Hospital Outcomes Of Community Hospital Outcomes Image Credit Industry Focus Coronavirus Disease Covid 19 Covid 19

Research reports full efficacy of Sotrovimab against BQ.1.1 viral replication in a non-human primate challenge model

Researchers used a non-human primate model to show that Sotrovimab, a commercial mAb also known as Xevudy, was fully effective against SARS-CoV-2 Omicron BA.5 sub-lineage and its derivatives, such as BQ.1.1.
Industry Focus Image Credit Sotrovimab Bound Omicron Coronavirus Disease Covid 19 Ngiotensin Converting Enzyme 2 Covid 19

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science